129 related articles for article (PubMed ID: 1696042)
1. The distribution of immuno-reactive tenascin in the epithelial-mesenchymal junctional areas of benign and malignant squamous epithelia.
Anbazhagan R; Sakakura T; Gusterson BA
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(1):59-63. PubMed ID: 1696042
[TBL] [Abstract][Full Text] [Related]
2. Tenascin expression in hyperproliferative skin diseases.
Schalkwijk J; Van Vlijmen I; Oosterling B; Perret C; Koopman R; Van den Born J; Mackie EJ
Br J Dermatol; 1991 Jan; 124(1):13-20. PubMed ID: 1704250
[TBL] [Abstract][Full Text] [Related]
3. Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma.
Ito T; Tsuji G; Ohno F; Nakahara T; Uchi H; Furue M
Mod Pathol; 2017 Jul; 30(7):919-927. PubMed ID: 28339425
[TBL] [Abstract][Full Text] [Related]
4. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma.
Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Chen SJ; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K
J Dermatol Sci; 2008 Sep; 51(3):210-5. PubMed ID: 18547788
[No Abstract] [Full Text] [Related]
6. The basal lamina in basal cell carcinoma, Bowen's disease, squamous cell carcinoma and keratoacanthoma: an immunoperoxidase study using an antibody to type IV collagen.
McArdle JP; Roff BT; Muller HK; Murphy WH
Pathology; 1984 Jan; 16(1):67-72. PubMed ID: 6371685
[TBL] [Abstract][Full Text] [Related]
7. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
Hughes JH; Robinson RA
Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin expression in skin tumors using an AMeX immunohistostaining method.
Koseki S; Ansai S; Aoki T; Hozumi Y; Mitsuhashi Y; Kondo S
J Dermatol; 2000 May; 27(5):307-11. PubMed ID: 10875196
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of the neutral cysteine protease bleomycin hydrolase in human skin.
Takeda A; Nonaka M; Ishikawa A; Higuchi D
Arch Dermatol Res; 1999 Apr; 291(4):238-40. PubMed ID: 10335922
[No Abstract] [Full Text] [Related]
10. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
11. [Expression of promyelocytic leukaemia protein in Bowen's disease, skin squamous cell carcinoma and basal cell carcinoma].
Wang Q; Ma H; Wang S; Ma Y; Zou X; Li R
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1075-7. PubMed ID: 23895857
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-8 immunoreactivity in malignant tumours of the skin.
Bornscheuer E; Schröder JM; Christophers E; Sticherling M
Acta Derm Venereol; 1996 May; 76(3):210-3. PubMed ID: 8800301
[TBL] [Abstract][Full Text] [Related]
13. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
[TBL] [Abstract][Full Text] [Related]
14. Expression of L-type amino acid transporter 1 in various skin lesions.
Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
[TBL] [Abstract][Full Text] [Related]
15. Assessment of cell proliferation in benign, premalignant and malignant skin lesions.
Bordbar A; Dias D; Cabral A; Beck S; Boon ME
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):229-35. PubMed ID: 17525640
[TBL] [Abstract][Full Text] [Related]
16. Tenascin distribution in basal cell carcinomas.
Stamp GW
J Pathol; 1989 Nov; 159(3):225-9. PubMed ID: 2480437
[TBL] [Abstract][Full Text] [Related]
17. P27 and mib1 expression in actinic keratosis, Bowen disease, and squamous cell carcinoma.
Oh CW; Penneys N
Am J Dermatopathol; 2004 Feb; 26(1):22-6. PubMed ID: 14726819
[TBL] [Abstract][Full Text] [Related]
18. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
19. Enhanced tenascin immunoreactivity in leukoplakia and squamous cell carcinoma of the oral cavity: an immunohistochemical study.
Shrestha P; Sakamoto F; Takagi H; Yamada T; Mori M
Eur J Cancer B Oral Oncol; 1994; 30B(2):132-7. PubMed ID: 7518275
[TBL] [Abstract][Full Text] [Related]
20. Keratin expression in normal skin and epidermal neoplasms demonstrated by a panel of monoclonal antibodies.
Perkins W; Campbell I; Leigh IM; MacKie RM
J Cutan Pathol; 1992 Dec; 19(6):476-82. PubMed ID: 1283171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
